A Combination of Low Dose Thalidomide with Prednisone in Myelofibrosis with Myeloid Metaplasia
A Decision Analysis of Allogeneic Stem Cell Transplantation for MDS: Delayed Transplantation for Low Risk MDS Is Associated with Imporved Outcome
A Multicenter Randomized Trial of Fludarabine and Mitoxantrone (FM) Plus Rituximab Versus CHOP Plus Rituximab as First-Line Treatment in Patients with Follicular Lymphoma (FL)
Allogeneic Stem Cell Transplantation in Adult Acute Lymphoblastic Leukemia (ALL) patients <50 years old in first complete remission(CR) A Donor vs no donor comparison in the EORTC ALL-3 Study.
Consolidation of AML Therapy with Autograft and Allograft Procedures Does not Negate the Poor Prognostic Impact of FLT-3 Internal Tandem Duplications: Results for UK MRC AML 10 and 12 Trials.
Effects of 40,000 IU Bi-Weekly (BIW) Induction Dose of Epoetin Alfa Followed by 40,000 IU Once Weekly (QW) in Low-Risk Myelodysplastic Syndrome (MDS) Patients.
FDG-PET Is Superior to Gallium Scintigraphy in the Staging and Follow-Up of Patients with De Novo Hodgkin's Disease: a Prospective, Blinded Comparison
Low Dose Decitabine for Elderly High Risk MDS Patients: Who Will Respond?
N998B: Multicenter Phase II Trial of Thalidomide (Thal) in Adult Patients with Myelodysplastic Syndromes (MDS)
Radiotherapy is Unnecessary in Elderly Patients With Localized Aggressive Non-Hodgkin's Lymphoma: Results of the GELA LNH 93-4 Study
Superiority of Chemotherapy Alone with the ACVBP Regimen over Treatment with Three Cycles of CHOP Plus Radiotherapy in Low Risk Localized Aggressive Lymphoma: The LNH93-1 GELA Study
Treatment of Hypereosinophilic Syndrome (HES) with Imatinib Mesylate
Treatment-Related Myelodysplastic Sydromes (t-MDS) after Autotransplants (AT) for Multiple Myeloma (MM)
Two Cycles ABVD Plus Extended Field Radiotherapy Is Superior to Radiotherapy Alone in Early Stage Hodgkin's Disease: Results of the German Hodgkin's Lymphoma Study Group (GHSG) Trial HD7

I Wish You Knew

How cancer patients have changed my life

View More

Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.

OncoLink OncoPilot

Frente a un nuevo diagnóstico de cáncer o de cambiar el curso de su tratamiento actual? Deje que nuestro personal de enfermería cáncer que ayudan a pasar!

Más información